debate: should dlbcl patients be treated differently based on cell of origin? - yes
Published 9 years ago • 1.8K plays • Length 12:05Download video MP4
Download video MP3
Similar videos
-
9:30
debate: should dlbcl patients be treated differently based on cell of origin? - no
-
15:16
debate: how should patients with abc type dlbcl be treated today? - r-chop
-
53:58
new options when diffuse large b cell lymphoma (dlbcl) doesn’t respond to treatment
-
33:05
debate: watch and wait in follicular lymphoma: should we treat immediately?
-
11:22
debate: follicular lymphoma - do not treat
-
8:21
diffuse large b-cell lymphoma (dlbcl) - aggressive b-cell neoplasm - non-hodgkin’s lymphoma
-
9:21
debate: a case of stage i follicular lymphoma - radiation /- systemic treatment
-
3:15
william’s car t-cell therapy experience
-
23:58
double hit lymphoma - what is it and how should we treat it?
-
4:13
diffuse large b cell lymphoma
-
6:55
debate: a case of stage i follicular lymphoma - observation
-
17:25
lymphoma ,stage 5
-
8:16
handbook on diffuse large b-cell lymphoma | dr amit shah, haematology-oncologist |part-1| mdforlives
-
26:29
what diffuse large b-cell lymphoma patients should receive therapy different from r-chop?
-
22:46
follicular lymphoma debate: does chemotherapy have a major role to play?
-
1:22:33
hallmarks of cancer: personal diffuse large b-cell lymphoma case study- pathway analysis
-
5:47
innovation at work - charlotte's battle with diffuse large b-cell lymphoma
-
3:00
what is diffuse large b-cell lymphoma (dlbcl)?
-
5:06
how is diffuse large b-cell lymphoma (dlbcl) treated?